Over 8,000 patients treated
The semaglutide and cagrilintide mix produced superior gains in waist circumference (average reduction of 15-17 cm), blood pressure (systolic BP reduced by 8-10 mmHg), lipid profiles (triglycerides reduced by 20-25%, HDL increased by 10-15%), glycemic control in diabetic participants (HbA1c reduced by 1.5-2.0%), and swelling markers (CRP reduced by 40-50%)
Additionally, oral semaglutide offers convenience for patients who prefer not to use injections
It is downregulated in gastric and colorectal cancers but upregulated in lung adenocarcinoma and breast tumors compared to normal tissue (Liu et al., 2017
The topical application is particularly relevant for localized infections, such as skin wounds or mucosal infections, where direct delivery to the affected area can enhance efficacy and minimize systemic side effects